Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Platelet glycoprotein llb/llla inhibitors

Table 4 Randomized clinical trials of platelet glycoprotein llb/llla inhibitors during reperfusion therapy for acute ST-elevation myocardial infarction... Table 4 Randomized clinical trials of platelet glycoprotein llb/llla inhibitors during reperfusion therapy for acute ST-elevation myocardial infarction...
Lincoff MA, Califf RM, Topol EJ. Platelet glycoprotein llb/llla inhibitors in coronary artery disease. J Am Coll Cardiol 2000 284 1549-1558. [Pg.55]

Bhatt DL, Topol EJ. Current role of platelet glycoprotein llb/llla inhibitors in acute coronary syndromes. JAMA 2000 35 1 103-1 I 15. [Pg.55]

The PAFfAGON Investigators. International, randomised, controlled trial of lamifiban (a platelet glycoprotein llb/llla inhibitor), heparin, or both in unstable angina. Circulation 1998 97 2386-395. [Pg.55]

Boersma E, Harrington R, Moliterno D, et al, Platelet glycoprotein llb/llla inhibitors in acute coronary syndromes A meta-analysis of all major randomised clinical trials, Lancet 2002 359 189-198. [Pg.56]

Topol EJ, Moliterno DJ, Herrmann HC, etal, Comparison of two platelet glycoprotein llb/llla inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. N Engl J Med 2001 344 1 888-1894. [Pg.56]

Deshmukh VR, Fiorella DJ, Albuquerque FC et al. Intraarterial thrombolysis for acute ischemic stroke preliminary experience with platelet glycoprotein llb/llla inhibitors as adjunctive therapy. Neurosurgery. 2005 56 46-54 discussion 54-45... [Pg.289]

Roffi M, Chew DP, Mukherjee D, Bhatt DL, White JA, Heeschen C, Hamm CW, Molitemo DJ, Califf RM, White HD, Kleiman NS, Theroux P, Topol EJ. Platelet glycoprotein llb/llla inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes. Circulation 2001 104 2767-2771. [Pg.196]

Rerkpattanapipat B Kotler MN, Yazdanfar S. Images in cardiovascular medicine. Rapid dissolution of massive intracoronary thrombosis with platelet glycoprotein llb/llla receptor inhibitor. Circulation 1999 99(22) 2965. No abstract available. [Pg.581]

Yoon HC, Miller FJ Jr, Using a peptide inhibitor of the glycoprotein llb/llla platelet receptor initial experience in patients with acute peripheral arterial occlusions. AJRAmJ Roentgenol 2002 178(3) 617—622. [Pg.582]

Inhibitors of AD P-depondont platelet aggregation, eg ticlopidine.clopidorgrel. and glycoprotein llb-llla ant.igomists.e.g. abeiximab, can be expected to form part of regimens for cardiovascular disease, as evidence accumulates. [Pg.584]

See other pages where Platelet glycoprotein llb/llla inhibitors is mentioned: [Pg.43]    [Pg.44]    [Pg.45]    [Pg.54]    [Pg.56]    [Pg.475]    [Pg.43]    [Pg.44]    [Pg.45]    [Pg.54]    [Pg.56]    [Pg.475]    [Pg.57]    [Pg.614]    [Pg.179]    [Pg.234]    [Pg.47]    [Pg.578]    [Pg.12]    [Pg.457]   


SEARCH



Glycoprotein inhibitors

Glycoprotein llb/llla inhibitors

Platelet glycoprotein

Platelet glycoprotein llb-llla

Platelet inhibitors

© 2024 chempedia.info